2-Acyl-tetrahydroisoquinoline-3-carboxylic acids: lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities.
Kazuya Otake, Satoru Azukizawa, Kenji Takahashi, Masaki Fukui, Michiko Shibabayashi, Hikaru Kamemoto, Masayasu Kasai, Hiroaki Shirahase
文献索引：Chem. Pharm. Bull. 59(7) , 876-9, (2011)
全文：HTML全文
摘要
2-Acyl-tetrahydroisoquinoline-3-carboxylic acid derivatives were synthesized and biologically evaluated. (S)-2-(2,4-Hexadienoyl)-7-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (14) showed peroxisome proliferator-activated receptor γ (PPARγ) and PPARα agonist activities and protein-tyrosine phosphatase 1B (PTP-1B) inhibitory activities. PPARγ agonist activity of 14 was comparable to that of rosiglitazone, and PTP-1B inhibitory activity was about 10-fold weaker than that of ertiprotafib, a PTP-1B inhibitor. Compound 14 showed high oral absorption in rats and potent hypoglycemic effects in KK-A(y) mice. In conclusion, 14 would be an excellent lead compound for a new type of anti-diabetic drug with triple actions.
相关化合物
| 结构式 | 名称/CAS号 | 分子式 | 全部文献 |
|---|---|---|---|
 |
(S)-1,2,3,4-四氢异喹啉-3-甲酸
CAS:74163-81-8 |
C10H11NO2 |
|
Acid catalysis in the formation of dioxopiperazines from pep...
1995-06-01 [Int. J. Pept. Protein Res. 45(6) , 567-73, (1995)] |
|
2-Substituted (S)-2-(3,3-dimethyl-1-oxo-10,10a-dihydroimidaz...
2011-01-15 [Bioorg. Med. Chem. 19 , 871-82, (2011)] |
|
Constrained phenylalanine analogues. Preferred conformation ...
1992-01-01 [Int. J. Pept. Protein Res. 40 , 222, (1992)] |
|
A novel series of (S)-2,7-substituted-1,2,3,4-tetrahydroisoq...
2011-01-01 [Chem. Pharm. Bull. 59(10) , 1233-42, (2011)] |
|
Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidi...
2011-01-01 [Biopolymers 96(1) , 97-102, (2011)] |